Studies on active transport of (E)-10-hydroxynortriptyline in the kidney and brain of rats: effects of propranolol and quinidine.

Studies in humans have given strong support of an active transport of (E)-10-hydroxynortriptyline [E)-10-OH-NT) in the kidney and from the cerebrospinal fluid. After 3 days of intraperitoneal injections of (E)-10-OH-NT (10 mg/kg t.i.d.) in a rat model, we investigated the effect of propranolol and quinidine (25 and 2.5 mg/kg injected 6 times during day 3) on the concentrations of (E)-10-OH-NT in urine, plasma (total and unbound) and brain. In a group of control rats the renal clearance of (E)-10-OH-NT varied 10-fold between rats, but was reproducible from Day 2 to Day 3 (r = 0.83; n = 8; p less than 0.05). Quinidine markedly decreased the renal clearance of both total and unbound (E)-10-OH-NT from plasma, while the effect of propranolol was less pronounced. There was no difference in the ratio of (E)-10-OH-NT concentrations in brain and plasma (unbound) between treated and control rats. We conclude that (E)-10-OH-NT is actively secreted in the rat proximal tubule and that the activity of this system varies between rats, but is constant in the individual rat. Quinidine, and to a less extent propranolol, inhibits this renal secretion. By the present methodology we could not demonstrate an active transport of (E)-10-OH-NT from brain to blood in the rat. Studies using other methods are needed to further elucidate this.

[1]  L. Bertilsson,et al.  Stereoselective efflux of (E)-10-hydroxynortriptyline enantiomers from the cerebrospinal fluid of depressed patients. , 1991, Pharmacology & toxicology.

[2]  L. Bertilsson,et al.  Stereoselective disposition of racemic E‐10‐hydroxynortriptyline in human beings , 1989, Clinical pharmacology and therapeutics.

[3]  A. Somogyi.  New insights into the renal secretion of drugs , 1987 .

[4]  L. Bertilsson,et al.  Little anticholinergic effect of E‐10‐hydroxynortriptyline compared with nortriptyline in healthy subjects , 1987, Clinical pharmacology and therapeutics.

[5]  Y. Sawada,et al.  Transport of cimetidine by the rat choroid plexus in vitro. , 1986, The Journal of pharmacology and experimental therapeutics.

[6]  D. Notterman,et al.  Stereoselective renal tubular secretion of quinidine and quinine , 1986, Clinical pharmacology and therapeutics.

[7]  M. Scheinin,et al.  Disposition of single oral doses of E‐10‐hydroxynortriptyline in healthy subjects, with some observations on pharmacodynamic effects , 1986, Clinical pharmacology and therapeutics.

[8]  S. Wright.  Transport of N1-methylnicotinamide across brush border membrane vesicles from rabbit kidney. , 1985, The American journal of physiology.

[9]  M. Takano,et al.  Cimetidine transport in rat renal brush border and basolateral membrane vesicles. , 1985, Life sciences.

[10]  L. Bertilsson,et al.  CSF and plasma levels of nortriptyline and its 10-hydroxy metabolite. , 1985, British journal of clinical pharmacology.

[11]  Y. Sawada,et al.  Saturable transport of cimetidine from cerebrospinal fluid to blood in rats. , 1985, Journal of pharmacobio-dynamics.

[12]  L. Bertilsson,et al.  Weak binding of 10-hydroxymetabolites of nortriptyline to rat brain muscarinic acetylcholine receptors. , 1984, Life sciences.

[13]  W. Pardridge,et al.  Blood-brain barrier transport and brain sequestration of propranolol and lidocaine. , 1984, The American journal of physiology.

[14]  Y. Sawada,et al.  Effect of quinidine on digoxin distribution and elimination in guinea pigs. , 1983, Journal of pharmaceutical sciences.

[15]  K. Speeg,et al.  Cimetidine and procainamide secretion by proximal tubules in vitro. , 1982, The American journal of physiology.

[16]  P. Turner,et al.  Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: evidence for central actions of beta-adrenoceptor antagonists. , 1981, British journal of clinical pharmacology.

[17]  L. Bertilsson,et al.  E‐ and Z‐10‐hydroxylation of nortriptyline: Relationship to polymorphic debrisoquine hydroxylation , 1981, Clinical pharmacology and therapeutics.

[18]  L. Bertilsson,et al.  Pronounced inhibition of noradrenaline uptake by 10-hydroxymetabolites of nortriptyline. , 1979, Life sciences.

[19]  S. Jacobsen,et al.  Influence of serum protein binding on the pharmacokinetics of quinidine in normal and anuric rats. , 2009, Acta pharmacologica et toxicologica.

[20]  C. Ross,et al.  Transport of organic cations and anions by choroid plexus. , 1976, The Journal of pharmacology and experimental therapeutics.

[21]  D. Shand,et al.  The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat. , 1973, The Journal of pharmacology and experimental therapeutics.

[22]  D. Shand,et al.  The Disposition of Propranolol , 1972 .

[23]  Y. Tochino,et al.  ACTIVE TRANSPORT OF QUATERNARY AMMONIUM COMPOUNDS BY THE CHOROID PLEXUS IN VITRO. , 1965, The American journal of physiology.